Keyphrases
Oral Cancer
91%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
62%
Oral Squamous Cell Carcinoma Cells
48%
Nivolumab
38%
Mandible
38%
Maxilla
29%
Rare Case Report
29%
Antitumor Immune Response
29%
Cluster of Differentiation 36 (CD36)
29%
Immune Cells
27%
Neoadjuvant Chemotherapy
22%
Apoptosis
22%
Pro-tumor
21%
Scimitar Syndrome
19%
Mucous Membrane Pemphigoid
19%
Laminin 332
19%
Desquamative Gingivitis
19%
Anti-PD-1 Antibody
19%
Response to Immunotherapy
19%
Lung Metastasis
19%
Aged Mice
19%
Durable Response
19%
Immune Impairment
19%
Verrucous Carcinoma
19%
Arthrosis
19%
Mandibular Condyle
19%
Helium Plasma Irradiation
19%
Temporomandibular Joint
19%
Proliferation Activity
19%
Reactive Oxygen Species Production
19%
Intra-arterial Cisplatin
19%
Salivary Duct Carcinoma
19%
Locally Advanced
19%
TS-1
19%
Induction Chemotherapy
19%
Combined Modality Therapy
19%
Migratory Behavior
19%
Intraoral
19%
Cyst
19%
X-ray Irradiation
19%
CD36 Expression
19%
Intraosseous
19%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
19%
Neurofibromatosis Type I
19%
Neurofibromatosis Type 1 (NF-1)
19%
Estrogen Receptor Status
19%
Adjuvant Chemotherapy
19%
Estrogen Receptor
19%
Neutrophil-to-lymphocyte Ratio
19%
Sarcoidosis
19%
Medicine and Dentistry
Mouth Squamous Cell Carcinoma
100%
Oral Cancer
60%
Nivolumab
38%
Squamous Cell Carcinoma Cell
38%
Lower Jaw
38%
Maxilla
29%
Cisplatin
22%
Neoadjuvant Chemotherapy
22%
Cicatricial Pemphigoid
19%
Desquamative Gingivitis
19%
Immunotherapy
19%
Neutrophil
19%
Verrucous Carcinoma
19%
Induction Chemotherapy
19%
Scimitar Syndrome
19%
Lung Metastasis
19%
Temporomandibular Joint
19%
Lymph Node Metastasis
19%
Osteoarthritis
19%
Neurofibromatosis Type I
19%
Malignant Peripheral Nerve Sheath Tumor
19%
Salivary Duct Carcinoma
19%
Sarcoidosis
19%
Radical Surgery
19%
Osteosarcoma
19%
Kalinin
19%
Adjuvant Chemotherapy
19%
Estrogen Receptor
19%
Receptor Expression
19%
Lymphocyte
19%
Neoplasm
18%
Recurrent Disease
16%
Neck
13%
Odontogenic Cyst
13%
Chemoradiotherapy
12%
Chemotherapy
12%
Metastatic Carcinoma
12%
Jaw
10%
Malignant Neoplasm
10%
Inferior Alveolar Nerve
9%
Third Molar
9%
Platelet Derived Growth Factor Receptor
9%
Uvomorulin
9%
Catenin
9%
Ankyloblepharon
9%
Nerve Injury
9%
Salivary Gland
9%
Mucoepidermoid Carcinoma
9%
Amnion
9%
Computed Tomography Angiography
9%
Immunology and Microbiology
Squamous Cell
45%
Squamous Cell Carcinoma Cell
45%
Immune Response
34%
CD36
29%
Immunocompetent Cell
28%
Immunity
25%
Lymphocyte
20%
T Cell
20%
Sulfasalazine
19%
Blood Plasma
19%
Nivolumab
19%
Neutrophil
19%
Immunotherapy
19%
Immune System
19%
Cytotoxic T-Cell
18%
T-Helper Cell
14%
Cancer Cell
14%
CTLA-4
12%
Regulatory T Cell
11%
Programmed Death-Ligand 1
10%
Carcinoma Cell
9%
Immunomodulation
9%
Lipid Metabolism
9%
Sirolimus
9%
Dendritic Cell
8%
Myeloid-Derived Suppressor Cell
8%
Cell Surface
7%
Oral Squamous Cell Carcinoma Cell Line
6%
Programmed Cell Death
6%
Immune Dysregulation
6%
Tumor Immunity
6%
Regulatory Cell
6%
T Cell Receptor
6%
Cell Proliferation
5%
Caspase
5%
CD83
5%